From: Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
Node
Vulnerability (%)
1
6.25
2
3
4
5
6
7
24.98
8
9
10
11
12
13
14
12.47
15
16
17
18
19
1.57
20
21
22
23
24